Article Information
PubMed
Print ISSN
Online ISSN
History
- Received December 2, 2011
- Accepted July 3, 2012
- Published online September 14, 2012.
Article Versions
- Earlier version (July 11, 2012 - 08:40).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright © 2012 by The American Society for Pharmacology and Experimental Therapeutics
Author Information
- Laura Pujols,
- Laura Fernández-Bertolín,
- Mireya Fuentes-Prado,
- Isam Alobid,
- Jordi Roca-Ferrer,
- Neus Agell,
- Joaquim Mullol, and
- César Picado
- Clinical and Experimental Respiratory Immunoallergy, Institut d'Investigacions Biomèdiques August Pi i Sunyer, and Centro de Investigaciones Respiratorias en Red de Enfermedades Respiratorias, Barcelona, Spain (L.P., L.F.-B, M.F.-P., I.A., J.R.-F., J.M., C.P); Unitat de Rinologia i Clínica de l'Olfacte, Servei d'Otorrinolaringologia (I.A., J.M.) and Servei de Pneumologia i Al·lèrgia Respiratoria (C.P.), Hospital Clínic, Barcelona, Spain; and Departament de Biologia Cel·lular, Immunologia i Neurociències, Universitat de Barcelona and Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain (N.A.)
- Address correspondence to:
Laura Pujols, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Lab 402, Hospital Clínic, Villarroel 170, 08036, Barcelona, Spain. E-mail: lpujols{at}clinic.ub.es
This work was presented previously in part: Pujols L, Fuentes M, Fernández-Bertolín L, Alobid I, Agell N, Roca-Ferrer J, Mullol J, and Picado C (2009) Effects of the reversible proteasome inhibitor MG262 on fibroblast proliferation and function, at the Seventh EAACI-GALEN Immunology Winter School; 2009 Feb 5–8; Davos, Switzerland. European Academy of Allergy and Clinical Immunology, Zurich, Switzerland.
J.M. and C.P. contributed equally to this work with senior responsibilities.